Protea Biosciences Group, Inc. 4
4 · Protea Biosciences Group, Inc. · Filed Feb 13, 2014
Insider Transaction Report
Form 4
HUGHES EDWARD JOSEPH
Chief Financial Officer
Transactions
- Award
Stock Option
2010-10-05$116438.00/sh+77,625$9,038,499,750→ 77,625 totalExercise: $1.50From: 2010-10-05Exp: 2020-10-05→ Common Stock (77,625 underlying)
Footnotes (1)
- [F1]Represents shares vested as of February 10, 2014.